Back to Trades
Total Value
$NaN
Filing Date
Jul 24, 2026
1 transactions
Trade Summary
On Feb 14, 2025, TOPOREK MICHAEL, Director, reported $NaN of Capstone Holding Corp. (CAPS) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Capstone Holding Corp.
- Ticker Symbol
- CAPS
- CIK
- 0000887151
Insider Information
- Name
- TOPOREK MICHAEL
- Role
- Director
- Location
- TINLEY PARK, IL
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Feb 14, 2025
- Accession Number
- 0001437749-26-024416
- Form Type
- 3
Want live alerts when TOPOREK MICHAEL trades again?
Download Insider Trades to track CAPS, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Consists of 121,774 shares controlled by Michael Toporek, through his control of BP Peptides, LLC. Brookstone Acquisition Partners XXI Corporation owns 81% of BP Peptides, LLC. Mr. Toporek owns approximately 30% of Brookstone Acquisition Partners XXI Corporation.
- (F2)Includes a warrant to purchase up to 6,322 shares of Common Stock issued to Brookstone Partners IAC, Inc., the investment manager of BP Peptides, LLC which is controlled by Matthew Lipman and Michael Toporek.